You are hereBiblio / Puredrug
|Publication Type||Case Study|
|Year of Publication||1996|
|Publisher||Association for Practical and Professional Ethics|
Puredrug, a large pharmaceutical company that has recently fallen on hard times, has the chance to sigh an $8 million sales contract with the Philippine Government for a new drug called Travenol used for treating viral infections, including measles. Purdrug's inventory includes a large batch of Travenol that was rejected by the U.S. Government based off a very sensitive test for toxic substances. This sensitive test found low dose of a toxic substance called endotoxin in the batch of Travenol, a level that would not have been caught using the old test. As the Phillipines rely solely on the old test, it would not be detected. Endotoxin causes a high fever, but no one can say if Puredrug's batch of Travenol contains enough endotoxin in patients. Last year half of the Philippine children who contracted measles died.
Sample Ethics Bowl Cases, 1993-96. Association for Practical and Professional Ethics, 1996.
|URL||Click here for the document|